Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel chelation-based route for Amikacin from Kanamycin A eliminates corrosive silanes, offering high purity and cost-effective manufacturing for global supply chains.
Novel solid-phase synthesis method for triazine libraries offering high purity and yield for anticancer drug discovery and commercial manufacturing.
Patent CN114702471B details green synthesis for Caronic Anhydride. Enhances yield and safety for pharmaceutical intermediates supply chain.
Patent CN103408520B details a high-yield arylation process for Alisertib intermediates, offering significant supply chain stability and cost reduction benefits for pharmaceutical manufacturers.
Discover the optimized 5-step synthesis of Budesonide from Prednisolone. Achieve higher yields and EP-compliant isomer ratios with this scalable pharmaceutical intermediate process.
Novel enzymatic process for high-purity scyllo-inositol. Reduces costs and environmental impact. Reliable supply chain partner for pharmaceutical intermediates manufacturing.
Patent CN112778238A details a novel Ir/Co dual-catalytic amidation method. This green chemistry approach eliminates stoichiometric coupling reagents, offering significant cost reduction and supply chain reliability for high-purity amide manufacturing.
Novel one-pot methylation and oxidation method for Imatinib intermediates reduces solvent use and improves yield for pharmaceutical manufacturing supply chains.
Novel synthesis of Ottensinin from Sclareolide. Reduced steps, mild conditions. Reliable supplier for pharmaceutical intermediates. Cost effective production.
Advanced synthesis method for Tenofovir Disoproxil Fumarate ensures high purity and cost efficiency for pharmaceutical supply chains globally.
Patent CN110655493A reveals a novel cyclization route for Oteracil Potassium, offering high purity and cost reduction in pharmaceutical intermediate manufacturing.
Novel patent CN114105800B enables safer synthesis of methyl 2 3 diaminobenzoate. Reduces hazardous steps and improves purity for reliable pharmaceutical intermediate supply chains.
Advanced synthesis of Cyclo(phenylalanyl-N-methylleucyl-leucyl-N-methylleucyl-leucyl) via CN102329376A. Offers high purity, mild conditions, and scalable routes for antitumor drug development.
Novel 5-step synthesis of Rivaroxaban intermediate offering high yield, low waste, and scalable production for global API manufacturers.
Novel synthesis route for desvenlafaxine succinate offering high purity and cost reduction for pharmaceutical supply chains ensuring reliable global availability and quality.
Novel zinc-mediated cyclization patent CN106928119A offers high yield Vilazodone intermediate with reduced waste and scalable production capabilities for global supply chains.
Patent CN108070012B details selective synthesis. Offers high purity and scalable production for corticosteroid supply chains.
Patent CN110951799B details a novel whole-cell enzymatic route for high-purity antibiotic intermediates, offering significant cost reduction and scalable manufacturing advantages.
Novel selective synthesis method for 6α-fluoro tetraene acetate intermediates. Reduces isomers, enhances supply chain reliability for corticosteroid manufacturing.
Patent CN108276324A details a novel oxidative coupling method for high-purity pharmaceutical intermediates offering significant supply chain and cost advantages for global buyers.